Current Opinion in Investigational Drugs, 7(4), 312-318
Animal studies administering 5-Amino-1MQ orally to diet-induced obese mice have shown dose-dependent reductions in body weight (typically 10-30% reduction compared to vehicle-treated obese controls over 4-12 week treatment periods), with the weight loss primarily reflecting fat mass reduction while lean mass is preserved or even increased
Theyll monitor your treatment
That means the advice youll find here is independent, expert-informed and designed to help you choose a supplement that works for you
The key differences that make this fragment scientifically interesting are: Absence of IGF-1 stimulation: Unlike full-length GH, this compound does not appear to stimulate hepatic IGF-1 production in laboratory models, an important distinction for researchers wishing to study metabolic GH-related pathways without the confounding variable of IGF-1 pathway activation
To unpack why the mechanism matters for dosing: NNMT sits at a metabolic crossroads